Adam Stibich, MD
Dermatology · Hot Springs, ARNPI 1093715047
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,315 of the $3,769 with a category attached, or 88.0%. It is spread thinly across 20 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for dermatology clinicians in AR, where the typical reported total is $3,769.
Across 193 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$844
- Sun Pharmaceutical Industries Inc.$756
- Amgen$509
- Johnson & Johnson$432
- Novartis$341
- Lilly USA, LLC$152
- plus $736 from 14 others
What the payments were for
- Food & beverage$3,31588%
- Education$45412%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $844 |
| Sun Pharmaceutical Industries Inc. | 34 | $756 |
| Amgen | 32 | $509 |
| Johnson & Johnson | 12 | $432 |
| Novartis | 20 | $341 |
| Lilly USA, LLC | 10 | $152 |
| Pfizer | 8 | $126 |
| Sanofi | 6 | $105 |
| E.r. Squibb & Sons, L.L.C. | 5 | $97 |
| UCB, Inc. | 5 | $85 |
| Genentech USA, Inc. | 5 | $74 |
| Bristol Myers Squibb | 1 | $67 |
| Biofrontera Inc. | 3 | $55 |
| Incyte Corporation | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| LEO Pharma Inc. | 1 | $18 |
| Biowound Solutions, Inc. | 1 | $17 |
| Dermavant Sciences, Inc. | 1 | $14 |
| Organon | 1 | $13 |
| Galderma Laboratories, L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Otezla$125
How this compares
$3,769 in reported general payments places this provider in the 50th percentile of 75 dermatology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 13 | $297,424 |
| OtezlaApremilast | 54 | $276,773 |
| Dupixent SyringeDupilumab | 15 | $67,610 |
| Fluorouracil | 203 | $14,888 |
| Triamcinolone Acetonide | 344 | $7,096 |
| Clobetasol Propionate | 148 | $6,296 |
| Imiquimod | 143 | $5,012 |
| Doxycycline Hyclate | 125 | $3,178 |
| Pimozide | 37 | $2,268 |
| Minoxidil | 173 | $1,945 |
| MethotrexateMethotrexate Sodium | 58 | $1,786 |
| Halobetasol Propionate | 26 | $1,551 |
| Tretinoin | 16 | $1,416 |
| Metronidazole | 25 | $1,411 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 33 | $916 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $509 | $276,77354 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 75 dermatology providers in Arkansas.
Other dermatology in Hot Springs
- Martin JohnsonHot Springs$3K
- Dowling StoughHot Springs$2K
- Rebecca GartnerHot Springs$828
- Sandra JohnsonFort Smith$543K
- Scott JacksonFayetteville$533K
- Mildred CliftonBentonville$92K
- Lance HenryFayetteville$39K
- Jennifer JacksPine Bluff$21K
- Zachary NahmiasJonesboro$15K
- Phillip StitesFort Smith$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.